Back to search
NSCLC Associated With Leptomeningeal Metastases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which NSCLC Associated With Leptomeningeal Metastases trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which NSCLC Associated With Leptomeningeal Metastases trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This will be a Phase II, open-label, single-arm, multicenter study of the efficacy and safety of osimertinib (80 mg orally once daily) in patients with LM assoc…
The goal of this clinical trial is to evaluate the clinical efficacy and safety of Furmonertinib in EGFR mutated NSCLC patients with leptomeningeal metastasis a…